The redirection of healthcare and life sciences resources to COVID-19 has taken focus from other areas of need, including antimicrobial resistance.
Jamie Culp
Advertisement
Articles by Jamie Culp
Advertisement
Latest Updated Articles
COVID and AMR: Crisis Reframes Antibiotics FightPublished: December 11th 2020 | Updated: January 6th 2023
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5